Neuro News

GLP-1 inhibitors, like Ozempic, are touted as the panacea to cure all ailments. Large sections of the population are using them for diabetic control and weight loss.  Studies have clearly shown a reduction in cardiovascular risks. Newer studies suggest that they may also be beneficial in neurodegenerative disorders, such as Alzheimer’s Disease (AD) and Parkinson’s […]

Parkinson’s Disease (PD) and Multisystem Atrophy (MSA) belong to a group of neurodegenerative disorders caused by abnormalities in the protein called synuclein. The changes associated with PD are due to neuron drop-out in a part of the brain called the Substantia Nigra while MSA affects more areas of the brain.  Both cause slowed movements, tremors,

Migraines are a real neurologic disorder, causing changes in chemicals and blood flow in the brain. They can be incredibly debilitating, affecting productivity and even causing temporary neurologic symptoms like motor weakness, vision changes, confusion, difficulty speaking, and even unstable walking. If they occur frequently, they can cause changes in MRI appearance.   One thing

A significant barrier in the Camp Lejeune litigation has been the stringent evidentiary requirement of “direct causation,” which demands a level of scientific certainty that is often unattainable given the historical and complex nature of toxic exposure scenarios. This standard has resulted in an unfair burden on plaintiffs, many of whom face insurmountable obstacles in

Cannabis is used by patients with chronic neurologic conditions to address many of their symptoms. There are two major forms of Cannabinoids – Tetrahydrocannabinol (THC) and cannabidiol (CBD). Both bind to receptors in the brain and spinal cord (the central nervous system). These receptors are believed to help with pain and the function of the

Besides taking advantage of the ground-breaking new treatments entering the market for the prevention and improvement of cognitive impairment in patients with mild cognitive impairment and Alzheimer’s Disease, people can take a proactive stance by adopting a diet that helps decrease the risk of developing dementia. The World Health Organization recently stated that certain diets

Difficulty sleeping is one of the 10 most common presentations of Parkinson’s disease (PD). Insomnia occurs in 27-80%  of PD patients and is most commonly experienced as frequent awakenings.  Other sleep disruptions include early morning awakening, difficulty falling asleep, nightmares, nighttime confusion, and delusions. Leaving the sleep disturbances unaddressed can accentuate cognitive decline.   Many

Societal costs of Alzheimer’s Disease In 2021, Alzheimer’s Disease (AD) was the fifth-leading cause of death among people age 65 and older. National healthcare costs for people with dementia are projected to reach $360 billion in 2024 and nearly $1 trillion in 2050. Caregiver costs of Alzheimer’s Disease In 2023, 11.5 million caregivers of people

Parkinson’s disease is a neurodegenerative disorder that develops slowly over years and which symptoms are most bothersome differs in different people. It is caused by a loss of dopamine-containing cells, specifically in an area of the brain called the substantia nigra. Here are ten symptoms that may be early signs of Parkinson’s disease: 1.Tremor- mostly

  Several new promising treatments for Alzheimer’s Disease (AD) have very recently become available. But they will only make a significant impact if we can diagnose Alzheimer’s at much earlier stages, even when the changes in the brain are not obvious clinically. Fortunately, there have been several very exciting new ways to diagnose AD before